higher than for each of the other treatment strategies but this was likely to have been due to the selection of an elderly population in this trial rather than a result of the intervention. CONCLUSIONS: The large uncertainty around the potential benefi ts of DOT strategies prohibits a conclusive statement regarding their cost-effectiveness in comparison to SAT.
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Phramongkutklao Hospital, Bangkok, Bangkok, Thailand; 2 Mahidol University, Bangkok, Thailand; 3 Ministry of Public Health, Nonthaburi, Nonthaburi, Thailand; 4 Ministry of Public Health, Bangkok, Thailand; 5 Rajvithi Hospital, Bangkok, Thailand OBJECTIVES: To determine the incidence of zoster-associated symptoms, as well as the impact of zoster on pain, quality of life, work loss, health-care utilization and direct health-care costs among 180 Thai patients seeking medical care for herpes zoster. METHODS: Study design: prospective observational study conducted in seven hospitals in Bangkok and vicinity, Thailand Study population: patients recently diagnosed herpes zoster, and meeting at least one other criterion, as follows: aged ≥50 years; aged ≥20 years with HIV-infection or receiving chemotherapy. All patients were scheduled for fi ve visits (i.e., at Day1, Day7, Month1, Month3, Month 6) for questionnaire based interview to determine zoster-associated pain (Zoster Brief Pain Inventory questionnaire), quality of life (EUROQOL 5-dimension questionnaire), work and productivity (multi-response questionnaire), and health-care utilization and cost. Statistical analysis: Descriptive statistics and Spearman rank correlation coeffi cients were used. RESULTS: Of 180 patients, whose mean (SD) age was 58.9 (13.82) years, 138 (76.7%), 34 (18.9%), and 8 (4.4%) were age ≥50 years, HIV-infected and immunosuppressed, respectively. Thirteen (7.2%) and 35 (20.6%) patients had zoster ophthalmicus and post-herpetic neuralgia (pain that persisted beyond 3 months of illness), respectively. Peak QoL lost was observed during the fi rst week of study and declined thereafter. Correlations between worst-pain scores and QoL were moderately high, r = 0.54. Of those 77 working patients, 57 reported that they were absent from work, either entired day or part of day, during zoster illness. Thirty patients reported sick leave and the median number of days off was 5.5 (1-52) days. Most patients required only two OPD visits for zoster illnesses. Other health-care services requirement included emergency-room visits (n = 2), ambulance services (n = 3), or hospital admissions (n = 7). The mean (SD) direct health-care cost was 3083.39 (5047.03) Thai Baht. CONCLUSIONS: Herpes zoster causes a signifi cant burden among those who develop it.
PODIUM SESSION I: RESEARCH ON METHODS

ME1 METHODOLOGICAL ISSUES IN THE DEVELOPMENT OF AN AUSTRALIAN ALGORITHM FOR THE EQ-5D
Viney R 1 , Norman R 1 , King M 2 , Street DJ 1 , Knox S 1 , Cronin P 1 1 University of Technology, Sydney, Broadway, NSW, Australia; 2 University of Sydney, Sydney, NSW, Australia OBJECTIVES: QALY weights for the EQ-5D are typically obtained through time trade-off (TTO) surveys using a sub-set (n = 17 or n = 43) of the 243 health states. Discrete choice experiments (DCEs) are a potentially more fl exible approach. We explore the development of EQ-5D algorithms based on both approaches and the impact of selection of health states in each. METHODS: We explore experimental designs for the TTO and DCE approaches via, respectively, a simulation study and a pilot study. An on-line panel sample (n = 1000) completed the DCE. Each choice set presented two health profi les (EQ-5D state and survival duration), and death. A population sample (n = 417) completed a computer based TTO task and the DCE. The TTO incorporated 198 plausible health states. Respondents were randomly assigned to value 11 health states and the worst health state. Separate models were estimated for the DCE and the TTO. RESULTS: Results of the DCE pilot suggest that different experimental designs lead to differences in both the mean and variance of parameter estimates. There is a loss of statistical effi ciency arising from using a reduced set of health states. The simulation study demonstrated that many interaction effects are not estimable from a TTO using only 43 health states. Models were estimated based on the functional form for the published algorithm for the EQ-5D, and allowing for interaction terms. While relatively few interaction terms are signifi cant, comparison tests demonstrate that inclusion of interaction terms improves the fi t of the model. CONCLUSIONS: Both approaches are broadly consistent with previously published EQ-5D algorithms, with some important differences. DCEs allows exploration of interactions between health states and duration that cannot be estimated with the TTO approach. In both approaches a design that allows for more extensive coverage of the EQ-5D space is appropriate.
ME2 VALIDATING THE ACCURACY OF A NOVEL METHOD FOR IDENTIFYING HEALTH CARE-ASSOCIATED INFECTIONS
Lee J, Imanaka Y, Sekimoto M, Nishikawa H, Ikai H, Motohashi T Kyoto University, Kyoto, Japan OBJECTIVES: The identifi cation of health care-associated infections (HAIs) is a necessary fi rst step for elucidating infection patterns and evaluating control measures. While the potential advantages to using administrative data for this purpose are recognized, previous attempts have proved unsuccessful. We have developed a novel method of HAI identifi cation based on a series of criteria involving antibiotic utilization patterns available in administrative data. The objective of this study was to validate the accuracy of our HAI identifi cation method using comparative analyses with chart reviewbased identifi cation. METHODS: We retrospectively and contemporaneously identifi ed HAIs in 584 gastrectomy patients admitted to four Japanese hospitals (A~D) using both our method and chart reviews. Chart review analysis was based on CDC criteria for nosocomial infections. The accuracy of our method was tested using Cohen's Kappa coeffi cient to quantify the non-random agreement between the two methods, as well as sensitivity, specifi city, positive predictive value (PPV) and negative predictive value (NPV). RESULTS: Overall HAI incidence was 21.6% based on chart review identifi cation. Cohen's Kappa coeffi cient was 0.78, and sensitivity and specifi city were 0.93 and 0.91, respectively. PPV was 0.75 and NPV was 0.98. CONCLU-SIONS: These results indicate that our method of identifi cation has high accuracy, and may be used to estimate HAIs in large populations of patients at the hospital level and above. While the NPV was observed to be higher than the PPV, the relatively low prevalence of HAI incidence may have infl uenced this result. It is important to note that this method was not designed to pinpoint individual infections, but rather to identify identifi cations in a large number of patients using administrative data with a far higher accuracy than previously available. Therefore, our method has applications for HAI identifi cation in large groups of patients, elucidating HAI patterns and trends, downstream economic evaluations and multi-institutional comparisons.
ME3 COST METHOD: A SIMPLE FRAMEWORK AND WORKING TOOL FOR BUDGET IMPACT ANALYSIS
Lo PC 1 , Shau WY 1 , Tarn YH 2 , Chern HD 1 1 Center for Drug Evaluation, Taipei, Taiwan; 2 Taiwan Pharmacist Association, Taipei, Taiwan BACKGROUND: Budget impact analysis was required for new drugs listing application to the National Health Insurance (NHI) in Taiwan over the last decade. However, a working model has not been proposed until now. OBJECTIVES: To provide a simple framework and working tool to estimate the likely fi nancial impact to NHI due to the submitted new drug. METHODS: To estimate the potential 5-year fi nancial impact annually if a new drug was reimbursed, proposed framework starts with the size of patient population and potential claim amount of existing drugs that the new drug is going to target, and taking into account the clinical position and usage of the new relative to the existing drugs. A simple working tool by using Excel spreadsheet was developed accompanying the framework. Only nine cells need to be input. They are grouped into three parts: 1) predicted annual number of new patients receiving new drug; 2) treatment duration; and 3) drug cost. The fi rst part should reference to local
